Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

243 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Completed

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

NCT02365766

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • IU Health Central Indiana Cancer Center Indianapolis, Indiana, United States
  • Community Regional Cancer Care Indianapolis, Indiana, United States
  • St. Vincent Hospital Indianapolis, Indiana, United States
View Trial Details
Completed

Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma

NCT02807636

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Coastal Integrative Cancer Care San Luis Obispo, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 204 locations
View Trial Details
Completed

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

NCT04666688

Conditions
Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +32 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Colorado Hospital Denver, Colorado, United States
  • Sarah Cannon Research Institute at Health One Denver, Colorado, United States
  • Sarah Cannon Research Institute, Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Completed

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

NCT03523572

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • UCLA - Medical Center Santa Monica, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Hospital & Clinics/Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 29 locations
View Trial Details

Related conditions